Cargando…

Ribavirin-Induced Anemia in Hepatitis C Virus Patients Undergoing Combination Therapy

The current standard of care for hepatitis C virus (HCV) infection – combination therapy with pegylated interferon and ribavirin – elicits sustained responses in only ∼50% of the patients treated. No alternatives exist for patients who do not respond to combination therapy. Addition of ribavirin sub...

Descripción completa

Detalles Bibliográficos
Autores principales: Krishnan, Sheeja M., Dixit, Narendra M.
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3033369/
https://www.ncbi.nlm.nih.gov/pubmed/21304937
http://dx.doi.org/10.1371/journal.pcbi.1001072